Supplemental material
Acta Oncologica
Volume 55, 2016 - Issue 3
Open access
1,097
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE: Urologic cancer
A five-factor biomarker profile obtained week 4–12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2
Anne V. SoerensenDepartment of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark, Correspondence[email protected]
, Poul F. GeertsenDepartment of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark,
, Ib J. ChristensenThe Finsen Laboratory, Rigshospitalet and Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark,
, Gregers G. HermannDepartment of Urology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark,
, Niels V. JensenDepartment of Oncology, Odense University Hospital, Odense, Denmark,
, Kirsten FodeDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark,
, Astrid PetersenDepartment of Pathology, Aalborg University Hospital, Aalborg, Denmark, and
, Rickard SandinPfizer Oncology, Sollentuna, Sweden
& Frede DonskovDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark,
show all
Pages 341-348
|
Received 19 May 2015, Accepted 02 Sep 2015, Published online: 08 Oct 2015
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.